Integrin Healthcare Private Limited

Integrin Healthcare Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24110TG2009PTC063270 Incorporated 02 April 2009 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹9.54 Cr
▲ 105% YoY
Net profit · FY 2025
₹2.08 Cr
Net margin 21.8%
EBITDA · FY 2025
₹2.12 Cr
EBITDA margin 22.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹92.81 Lakh
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹17 Lakh
Company age
17 yrs
Est. 2009
Directors on board
3
As per MCA filings

About Integrin Healthcare Private Limited

Data last updated:

Integrin Healthcare Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2009PTC063270. Its GSTIN is 36AADCB7333H1ZR (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹92.81 Lakh. It was formerly known as Bindu Pharmaceuticals Private Limited. It is led by directors including Dhana Laxmi Marikanti and Sreedhar Tirumala.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #5 – 9 – 285/9 Plot No.64/A Rajiv Gandhi Nagar Prashanthi Nagar Kukatpally Hy, Hyderabad, Telangana, India – 500072.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.54 Cr, a growth of 105% compared to the previous year. For the same year it recorded a net profit of ₹2.08 Cr (net margin 21.8%) and EBITDA of ₹2.12 Cr (EBITDA margin 22.2%). Revenue has grown at a compounded annual rate (CAGR) of 117% over three years and 181% over five years.

The company is associated with 1 brand: Bindu Pharmaceuticals. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹17 Lakh on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website integrinhealthcare.com.

Company details

CIN U24110TG2009PTC063270
Registration Number 063270
Incorporation Date 02 April 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Integrin Healthcare has one previous CIN (Corporate Identification Number): U24110AP2009PTC063270. The current CIN is U24110TG2009PTC063270, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24110TG2009PTC063270Current
U24110AP2009PTC063270Previous

Contact details

Integrin Healthcare Private Limited's registered office is in Hyderabad, Telangana. Its website is integrinhealthcare.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    #5 – 9 – 285/9 Plot No.64/A Rajiv Gandhi Nagar Prashanthi Nagar Kukatpally Hy, Hyderabad, Telangana, India – 500072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Integrin Healthcare Private Limited, buy the company report.

Comprehensive company report
Integrin Healthcare Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Integrin Healthcare operates one associated brand: Bindu Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Produces high-quality pharmaceutical products, including tablets, capsules, pellets, and granules.bindupharma.com

Business activity

The main business activity of Integrin Healthcare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Integrin Healthcare Private Limited, buy the company report.

Financials of Integrin Healthcare Private Limited

FY 2025 filings available

Integrin Healthcare Private Limited reported revenue of ₹9.54 Cr (up 105% YoY) for FY 2025.

Revenue · FY 2025
₹9.54 Cr ▲ 105%
Net profit · FY 2025
₹2.08 Cr margin 21.8%
EBITDA · FY 2025
₹2.12 Cr margin 22.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 105%
3 years · compounded
▲ 117%
5 years · compounded
▲ 181%
EBITDA CAGR growth
1 year
▲ 368%
3 years · compounded
▲ 90%
5 years · compounded
▲ 43%

Revenue has grown at a compounded annual rate (CAGR) of 181% over five years, including 105% growth in the latest year. EBITDA rose 368% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.12 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.08 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.2%
Net Profit Margin21.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Integrin Healthcare Private Limited, buy the company report.

Board of directors of Integrin Healthcare Private Limited

Integrin Healthcare has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dhana Laxmi MarikantiDirector22 Jul 20215 Years 3 MonthsCurrent
Sreedhar TirumalaDirector22 Jan 20242 Years 9 MonthsCurrent
Srinivas Rao MarikantiDirector21 Oct 20206 Years 0 MonthsCurrent

Peer comparison

Integrin Healthcare Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tulsi Amrit Private Limited₹9.54 Cr (FY 2024)8.0%Indore, Madhya Pradesh, India
Integrin Healthcare Private Limitedthis company₹9.54 Cr (FY 2025)₹2.08 Cr21.8%105.0%Hyderabad, Telangana, India
Steriscience Specialties Private Limited₹9.53 Cr (FY 2025)238.0%Thane, Maharashtra, India
Willmark Pharmaceuticals Private Limited₹9.49 Cr (FY 2025)-7.0%Punjab, India
Health Secure (India) Private Limited₹9.46 Cr (FY 2021)0.0%Nashik, Maharashtra, India

To see the full peer comparison of Integrin Healthcare Private Limited, buy the company report.

Auditor

Integrin Healthcare Private Limited is audited by VASG & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
VASG & ASSOCIATESFY 2023006070S

Shareholding

The shareholding of Integrin Healthcare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Integrin Healthcare Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
₹17 Lakh
Breakdown by lending institutions
Others₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 2025101173722Others₹2 CrOpen
20 May 201410512995Lakshmi Vilas Bank Limited₹17 LakhSatisfied

To see the full charge records of Integrin Healthcare Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Integrin Healthcare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Integrin Healthcare has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AADCB7333H1ZRTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Integrin Healthcare Private Limited, buy the company report.

Recent activity

Integrin Healthcare Private Limited has 10 board changes on record since 2017: 3 appointments and 7 cessations. The latest: Dhana Laxmi Marikanti ceased to be Additional Director on 29 Sep 2024.

Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101173722 was registered on 18 Oct 2025.
AGM
Integrin Healthcare Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Integrin Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Dhana Laxmi Marikanti ceased to be Additional Director.
Ceased
Sreedhar Tirumala ceased to be Additional Director.
Ceased
Srinivas Rao Marikanti ceased to be Additional Director.
Appointed
Sreedhar Tirumala was appointed as Director.
Ceased
Duggireddy Hima Bindu ceased to be Director.
Ceased
Venna Ramakrishna Reddy ceased to be Director.
Charges
A charge registered on 20 May 2014 via Charge ID 10512995 with Lakshmi Vilas Bank Limited was fully satisfied on 07 Jan 2022.
Appointed
Dhana Laxmi Marikanti was appointed as Director.
Appointed
Srinivas Rao Marikanti was appointed as Director.

4 earlier events are in the company report.

Frequently asked questions

Integrin Healthcare is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 2009 (17+ years old) and is registered under CIN U24110TG2009PTC063270.

Integrin Healthcare has 3 current directors:

The latest financial statements of Integrin Healthcare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Integrin Healthcare is 36AADCB7333H1ZR, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Integrin Healthcare is U24110TG2009PTC063270. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Integrin Healthcare has 7 court cases on record: 3 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.

Integrin Healthcare was incorporated on 02 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Integrin Healthcare by revenue are Tulsi Amrit Private Limited, Steriscience Specialties Private Limited, Willmark Pharmaceuticals Private Limited, Health Secure (India) Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dhana Laxmi Marikanti ceased to be Additional Director on 29 Sep 2024. Sreedhar Tirumala ceased to be Additional Director on 29 Sep 2024. Srinivas Rao Marikanti ceased to be Additional Director on 29 Sep 2024. Integrin Healthcare has 10 board changes on record in total.

Integrin Healthcare can be reached through the website integrinhealthcare.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Integrin Healthcare is at #5 – 9 – 2859 Plot No.64A Rajiv Gandhi Nagar Prashanthi Nagar Kukatpally Hy, Hyderabad, Telangana, India – 500072.